<DOC>
	<DOCNO>NCT00916396</DOCNO>
	<brief_summary>Hypoactive Sexual Desire Disorder ( HSDD ) common syndrome characterize low sexual desire causing mark distress . The involvement DHEA sexual function unknown , however , DHEA treatment increase desire depressed subject . In current research , treat 45 woman men suffer low sexual desire DHEA placebo 6 week . The study 's primary goal determine effect DHEA treatment sexual desire , find connection level hormone change desire . Outcome measure include hormonal level psychological state . Our secondary goal compare baseline hormone measure individual low sexual desire normal control . For purpose measure hormonal baseline level among 20 normal subject .</brief_summary>
	<brief_title>Dehydroepiandrosterone ( DHEA ) Treatment Women Men Experiencing Hypoactive Sexual Desire Disorder</brief_title>
	<detailed_description>Hypoactive Sexual Desire Disorder ( HSDD ) common syndrome adult woman men , characterize severe deficiency desire sexual activity , cause mark distress . There data androgen testosterone beneficial effect condition . DHEA neurosteroid metabolize testosterone estrogen , assume importance regulation sexual libido . The direct involvement DHEA regulation sexual function unknown , however , DHEA treatment improve libido midlife-onset depressed subject . In study , treat woman men suffer HSDD DHEA . The study 's first objective determine effect DHEA treatment sexual libido menopausal woman young mid-aged men . The secondary objective compare baseline measure DHEA , androgens , neurosteroids , individual HSDD control . Furthermore , investigate possible correlation plasma urine level several neurosteroids change measure libido . Fifty woman men diagnose HSDD treat either 100 mg DHEA placebo 6 week , double-blind , placebo-controlled study . Outcome measure include several 17-Ketosteroids , DHEAS bioavailable testosterone . Psychological outcome measure include sexual function , mood well-being . Twenty control without HSDD also recruit determine compare baseline level neurosteroids .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Hypokinesia</mesh_term>
	<mesh_term>Sexual Dysfunctions , Psychological</mesh_term>
	<mesh_term>Dehydroepiandrosterone</mesh_term>
	<criteria>Woman participate research menopausal phase ( year postmenopause ) age 65 . Man age range 18 65 . Individuals suffer significant systemic illness , hormonal illness , alcoholism , drug abuse , major depression , `` Mano/matroagia '' hypogonadism . Additionally , individual treat androgen , antidepressant medication may cause disorder sexual desire . Man diagnose suffer prostate carcinoma , BHP show PSA level 2.5 include . Woman treat HRT suffer follow disease include : breast carcinoma , ovarian uterus cancer first grade family history one mention .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2009</verification_date>
</DOC>